Life SciencesMentor

Dr. Aaron Nelson is a Principal at Novartis Venture Fund in Cambridge, MA, USA. Prior to joining NVF, he was an investor at dRx Capital, the joint investment company of Novartis and Qualcomm, focused on Digital Medicine, therapeutic chemical and biological technologies. Previously, Aaron worked on technology strategy across multiple Business Units within Novartis, including Strategic Project Leader for the Trials of The Future program and Group Head in the Investigative Toxicology organization. Through his experience, Nelson has gained a broad background in biomedical innovation, developed through experiences in academia and pharma.